Gara Jalqabaatti › Infekshinii Vaayirasii
Qorannoo klinikaalii Infekshinii Vaayirasii Ameerikaa Keessatti hirmaatuu
Qorannoo 31 Infekshinii Vaayirasii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Washington, DCQorannoo 12
- Boston, MAQorannoo 6
- Houston, TXQorannoo 6
- Hialeah, FLQorannoo 5
- Baltimore, MDQorannoo 5
- Atlanta, GAQorannoo 4
- Cincinnati, OHQorannoo 4
- Dallas, TXQorannoo 4
- Columbus, OHQorannoo 4
- Los Angeles, CAQorannoo 3
- Worcester, MAQorannoo 3
- Miami, FLQorannoo 3
- Tampa, FLQorannoo 3
- San Francisco, CAQorannoo 3
- Durham, NCQorannoo 3
- Boise, IDQorannoo 3
- Salt Lake City, UTQorannoo 3
- St. Louis, MOQorannoo 3
- Omaha, NEQorannoo 3
- New York City, NYQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 11
- ColoradoQorannoo 3
- Distaarikii KoloombiyaaQorannoo 5
- FloridaQorannoo 6
- GeorgiaQorannoo 5
- IdahoQorannoo 3
- IllinoisQorannoo 3
- KentuckyQorannoo 3
- LouisianaQorannoo 3
- MarylandQorannoo 14
- MassachusettsQorannoo 6
- MichiganQorannoo 3
- MissouriQorannoo 4
- NebraskaQorannoo 3
- New YorkQorannoo 6
- North CarolinaQorannoo 5
- OhioQorannoo 9
- PennsylvaniaQorannoo 5
- South CarolinaQorannoo 3
- TexasQorannoo 9
- UtahQorannoo 4
- VirginiaQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00006518A Study of COVID-19 Vaccine(s) in Children and Adults
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07798648The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01011712Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07706686A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06679140Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
6 Months – 120 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
2 Months – 115 Years · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04419870Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT04230356HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388Third Party Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 2
2 Days · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02532452Donor-Derived Viral Specific T-cells (VSTs)
Namoota walitti qabaa jiraSadarkaa 1/2
4 Weeks · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02048332A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 40 hanga 64 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 1 hanga 120 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin hundi · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 79 Years · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
6 Months · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Namoota walitti qabaa jiraSadarkaa 1
3 Months – 80 Years · Saalaa hunda · Haaromfame 26-Ama-2026 · NCT04691622Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.